ZInvestorHunting

David Kenji Chang

Solo GP · Yorba Linda, California

US Angel

Named as the only individual (Managing Partner of the General Partner of the Issuer) on the Form D for A-N Partners Fund I, LP, a $7M venture fund (Jul 2024). Also a non-executive director at 3 startups that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

82/ 100
High Conviction AngelLatest deal Jan 2025
Deal VelocityLatest deal Jan 2025USA & Europe pipeline
Typical Check$75K–$200KPre-Seed / Seed
Primary FocusHealthcare, Biotech & PharmaPre-seed to Series B
Direct AccessWarm Intro Recommended1-click pitch match

Why David Kenji Chang holds a 82/100 confidence score

  • Verified past startup investments on public record
  • Target check sizes calibrated between $75K–$200K
  • Clear domain thesis in Healthcare, Biotech & Pharma
  • Named as the only individual (Managing Partner of the General Partner of the Issuer) on the Form D for A-N Partners Fund I, LP, a $7M venture fund (Jul 2024). Also a non-executive director at 3 startups that filed Form D.

Building in Healthcare, Biotech & Pharma? See how well your pitch deck matches David Kenji Chang’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (Managing Partner of the General Partner of the Issuer) on the Form D for A-N Partners Fund I, LP, a $7M venture fund (Jul 2024). Also a non-executive director at 3 startups that filed Form D.

Source: SEC Form D: A-N Partners Fund I, LP (Jul 10, 2024) · 3 more sources

Stages
Pre-seed to Series B
Typical check (est.)
$75K–$200K
Verified deals
4 on file
Latest activity
Jan 2025
Pitch Readiness

Is David Kenji Chang a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does David Kenji Chang back?

HealthcareBiotech & Pharma

Verified investments & deal activity

4 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • Ventiva

    Board seat on the company's SEC filing · CA

    Jan 2025
  • A-N Partners Fund I, LP

    Invested through a fund

    Jul 2024
  • 1200 Pharma

    Board seat on the company's SEC filing · CA

    Apr 2024
  • Long Bridge Medical

    Board seat on the company's SEC filing · CA

    Nov 2023

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to David Kenji Chang

Founders raising in health and bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
John Parker

Solo GP · Sudbury, MA

86/100
$200K–$600KActive Nov 2025
HealthcareBiotech & Pharma
Adam Rosenwach

Solo GP · New York, NY

85/100
Active Jun 2026
Biotech & PharmaHealthcare
Tal Wenderow

Solo GP · New York, NY

85/100
Active Jun 2026
Biotech & PharmaHealthcare
Suzanne Fletcher

Solo GP · Portola Valley, CA

86/100
$300K–$900KActive Mar 2026
HealthcareAI & MLFintech+1
Adam E. Fine

Solo GP · New York, NY

83/100
$1.5M–$4.5MActive Nov 2025
HealthcareBiotech & Pharma
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against David Kenji Chang and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.